Mitrakou, A <br/><br/>
Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Aug 1998 
 - 657-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO;2-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Deoxynojirimycin--analogs & derivatives<br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>C-Peptide--blood<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Enzyme Inhibitors--adverse effects<br/>Fasting<br/>Female<br/>Follow-Up Studies<br/>Glucosamine--adverse effects<br/>Glycated Hemoglobin--analysis<br/>Glycoside Hydrolase Inhibitors<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Imino Pyranoses<br/>Insulin--therapeutic use<br/>Male<br/>Middle Aged<br/>Postprandial Period<br/>Time Factors